CJC-1295 (w/o DAC) + Ipamorelin (Blend)

CJC 1295 without DAC, also known as Modified GRF (1-29), is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), designed for endocrine system research. This 29 amino acid peptide is a truncated form of GHRH, suitable for scientific study.

CJC-1295 (No DAC) is widely utilized in vitro to explore short-duration GHRH analog activity, pituitary receptor signaling, and cyclic AMP–mediated intracellular pathways. Ipamorelin is frequently employed to examine selective GHSR-associated cascades, including calcium flux responses, second-messenger formation, and peptide–receptor binding dynamics.

When used in controlled mechanistic models, this blend allows evaluation of complementary pathway modulation, synergistic biochemical effects, and coordinated receptor-specific intracellular signaling. The fixed-ratio formulation ensures consistent composition for in-vitro assays requiring reproducible multi-peptide interaction profiles.

• Research-grade peptide for laboratory and scientific use
• Produced to the highest purity and stability standards
• Lyophilized (freeze-dried) for optimal preservation
• Available in multiple quantities to support diverse research needs

We provide PEPTIDES of the highest purity and quality to ensure accuracy and reliability in scientific research.

Each product undergoes rigorous testing and quality control to meet the highest industry standards.

Quality & Formulation

Manufactured under strict quality control standards, the products are supplied in lyophilized powder form, ensuring:

    ✔ Enhanced stability during storage
    ✔ Consistent purity across batches
    ✔ Reliable reproducibility for laboratory research

By purchasing from Begin-Peptides, you agree to the following:

Research Use Only – All products are strictly for research purposes and are not intended for human, therapeutic, diagnostic or clinical use.

Not Medical Products – Our products are not medical items and must not be marketed, sold, or used as such.